REG - Infrastrata PLC - Results of General Meeting

Harland & Wolff groupAnnouncement

27/07/2020 11:55

RNS Number : 1882U
  
Infrastrata PLC
  
27 July 2020
  
 

27 July 2020
 
InfraStrata plc
("InfraStrata" or the "Company")
 
Results of General Meeting
InfraStrata plc (AIM: INFA), the UK quoted company focused on strategic infrastructure projects and physical asset lifecycle management, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Details of the votes cast by proxy will be published on the Company's website shortly.
 
Accordingly, the Company will raise a total of approximately £9.0 million (before expenses) through the Placing. An application has been made for the 1,791,428,683 Ordinary Shares to be admitted to trading on AIM, which is expected to take place at 8.00 a.m. on 28 July 2020.
Following Admission, the Company's issued share capital will comprise 6,416,008,200 Ordinary Shares, of which none are held in treasury. The above figure of 6,416,008,200 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 10 July 2020.
For further information, please visit www.infrastrataplc.com or contact:
 



InfraStrata plc
John Wood, Chief Executive

Seena Shah, PR & Communications Manager 
 


+44 (0)20 3900 2122
 




Cenkos Securities plc (Nominated Adviser & Broker)
Stephen Keys / Cameron MacRitchie (Corporate Finance)

Michael Johnson (Sales)
 


+44 (0)20 7397 8900



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ROMKKOBPKBKDKOB